Basit öğe kaydını göster

Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial

dc.contributor.authorGokdeniz, Tayyar
dc.contributor.authorDuran, Nilufer Eksi
dc.contributor.authorOzkan, Mehmet
dc.contributor.authorGunduz, Sabahattin
dc.contributor.authorGursoy, Ozan Mustafa
dc.contributor.authorKarakoyun, Suleyman
dc.contributor.authorASTARCIOĞLU, MEHMET ALİ
dc.contributor.authorKalcik, Macit
dc.contributor.authorAykan, Ahmet Cagri
dc.contributor.authorCakal, Beytullah
dc.contributor.authorBayram, Zubeyde
dc.contributor.authorOguz, Ali Emrah
dc.contributor.authorErturk, Emre
dc.contributor.authorYesin, Mahmut
dc.contributor.authorEsen, Ali Metin
dc.contributor.authorYildiz, Mustafa
dc.date.accessioned2021-03-02T21:05:08Z
dc.date.available2021-03-02T21:05:08Z
dc.date.issued2015
dc.identifier.citationOzkan M., Gunduz S., Gursoy O. M. , Karakoyun S., ASTARCIOĞLU M. A. , Kalcik M., Aykan A. C. , Cakal B., Bayram Z., Oguz A. E. , et al., "Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial", AMERICAN HEART JOURNAL, cilt.170, sa.2, ss.409-419, 2015
dc.identifier.issn0002-8703
dc.identifier.otherav_0553e342-c668-4bf4-aa7a-77f937375ead
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/9460
dc.identifier.urihttps://doi.org/10.1016/j.ahj.2015.04.025
dc.description.abstractBackground Low-dose (25 mg), slow infusion (6 hours) of tissue-type plasminogen activator (t-PA) with repetition as needed has been shown to provide effective and safer thrombolysis in patients with prosthetic valve thrombosis (PVT). Further prolonging the infusion time may be rational with regard to reducing complication rates without reducing success rates. We aimed to investigate the efficacy and safety of ultraslow (25 hours) infusion of low-dose (25 mg) alteplase (t-PA) for PVT.
dc.language.isoeng
dc.subjectTıp
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectKardiyoloji
dc.subjectCardiology and Cardiovascular Medicine
dc.subjectHealth Sciences
dc.titleUltraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial
dc.typeMakale
dc.relation.journalAMERICAN HEART JOURNAL
dc.contributor.departmentKafkas Üniversitesi , ,
dc.identifier.volume170
dc.identifier.issue2
dc.identifier.startpage409
dc.identifier.endpage419
dc.contributor.firstauthorID2507565


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster